| 000 | 02858cam a2200469Ia 4500 | ||
|---|---|---|---|
| 001 | ocn798710645 | ||
| 003 | OCoLC | ||
| 005 | 20170612141629.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 120710s2012 enka ob 001 0 eng d | ||
| 040 |
_aDG1 _beng _cDG1 _dOCLCO _dMYG _dOCLCQ _dOCLCF _dOCLCA _dOCLCQ _dDEBBG |
||
| 020 |
_a9781118325421 _q(electronic bk.) |
||
| 020 |
_a1118325427 _q(electronic bk.) |
||
| 029 | 1 |
_aAU@ _b000049595551 |
|
| 029 | 1 |
_aGBVCP _b79003803X |
|
| 029 | 1 |
_aNZ1 _b15915099 |
|
| 029 | 1 |
_aDEBBG _bBV043394661 |
|
| 035 | _a(OCoLC)798710645 | ||
| 037 |
_a10.1002/9781118325421 _bWiley InterScience _nhttp://www3.interscience.wiley.com |
||
| 050 | 4 |
_aRM409 _b.A58 2012eb |
|
| 082 | 0 | 4 |
_a615.7922 _223 |
| 049 | _aMAIN | ||
| 245 | 0 | 0 |
_aAntibacterial agents : _bchemistry, mode of action, mechanisms of resistance, and clinical applications / _cRosaleen Anderson [and others]. |
| 260 |
_aOxford : _bWiley-Blackwell, _c2012. |
||
| 300 |
_a1 online resource (xiv, 363 pages) : _billustrations (some color) |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 505 | 0 | _aIntroduction to microorganisms and antibacterial chemotherapy -- Agents targeting DNA -- Agents targeting metabolic processes -- Agents targeting protein synthesis -- Agents targeting cell-wall synthesis. | |
| 504 | _aIncludes bibliographical references and index. | ||
| 520 |
_a"Antibacterial agents act against bacterial infection either by killing the bacterium or by arresting its growth. They do this by targeting bacterial DNA and its associated processes, attacking bacterial metabolic processes including protein synthesis, or interfering with bacterial cell wall synthesis and function. Antibacterial Agents is an essential guide to this important class of chemotherapeutic drugs. Compounds are organised according to their target, which helps the reader understand the mechanism of action of these drugs and how resistance can arise. The book uses an integrated "lab-to-clinic" approach which covers drug discovery, source or synthesis, mode of action, mechanisms of resistance, clinical aspects (including links to current guidelines, significant drug interactions, cautions and contraindications), prodrugs and future improvements."-- _cProvided by publisher. |
||
| 588 | 0 | _aPrint version record. | |
| 650 | 0 | _aAntibacterial agents. | |
| 650 | 7 |
_aAntibacterial agents. _2fast _0(OCoLC)fst00810407 |
|
| 655 | 4 | _aElectronic books. | |
| 700 | 1 | _aAnderson, Rosaleen J. | |
| 710 | 2 | _aWiley InterScience (Online service) | |
| 776 | 0 | 8 |
_iPrint version: _tAntibacterial agents. _dOxford : Wiley-Blackwell, 2012 _z9780470972441 _w(OCoLC)792747352 |
| 856 | 4 | 0 |
_uhttp://onlinelibrary.wiley.com/book/10.1002/9781118325421 _zWiley Online Library |
| 994 |
_a92 _bDG1 |
||
| 999 |
_c206021 _d206021 |
||